ATE116547T1 - Alginsäure enthaltende arzneisuspension. - Google Patents
Alginsäure enthaltende arzneisuspension.Info
- Publication number
- ATE116547T1 ATE116547T1 AT92400830T AT92400830T ATE116547T1 AT E116547 T1 ATE116547 T1 AT E116547T1 AT 92400830 T AT92400830 T AT 92400830T AT 92400830 T AT92400830 T AT 92400830T AT E116547 T1 ATE116547 T1 AT E116547T1
- Authority
- AT
- Austria
- Prior art keywords
- suspension containing
- algic acid
- medicinal suspension
- concentrations
- medicinal
- Prior art date
Links
- 239000000725 suspension Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 235000010443 alginic acid Nutrition 0.000 abstract 2
- 229920000615 alginic acid Polymers 0.000 abstract 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 229940072056 alginate Drugs 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9103894A FR2674437B1 (fr) | 1991-03-29 | 1991-03-29 | Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE116547T1 true ATE116547T1 (de) | 1995-01-15 |
Family
ID=9411310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92400830T ATE116547T1 (de) | 1991-03-29 | 1992-03-26 | Alginsäure enthaltende arzneisuspension. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0506563B1 (de) |
| AT (1) | ATE116547T1 (de) |
| DE (1) | DE69201077T2 (de) |
| DK (1) | DK0506563T3 (de) |
| ES (1) | ES2067302T3 (de) |
| FR (1) | FR2674437B1 (de) |
| GR (1) | GR3015383T3 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5302373A (en) * | 1993-06-10 | 1994-04-12 | Church & Dwight Co., Inc. | Liquid mouthwash containing a particulate bicarbonate suspension |
| NZ260933A (en) * | 1993-07-16 | 1996-07-26 | Hercules Inc | Cation-complexed polysaccharides; use in foods and pharmaceuticals |
| WO1998034877A2 (de) * | 1997-02-10 | 1998-08-13 | Tetra Werke Dr. Rer. Nat. Ulrich Baensch Gmbh | Zwei-komponentenmittel zur wasserklärung von tropischen zierfischaquarien |
| DE102004063612B4 (de) * | 2004-01-02 | 2017-01-12 | Manfred Helms | Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung |
| DE102008019339A1 (de) * | 2008-04-16 | 2009-10-22 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum |
| AU2017364103C1 (en) | 2016-11-28 | 2023-12-21 | Kenvue Brands Llc | Liquid compositions comprising a mucoadhesive agent |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4744986A (en) * | 1986-03-07 | 1988-05-17 | Rorer Pharmaceutical Corporation | Process for the preparation of a viscosity-stable antacid composition |
| FR2636532B1 (fr) * | 1988-09-20 | 1993-11-19 | Glaxo Group Ltd | Compositions pharmaceutiques |
-
1991
- 1991-03-29 FR FR9103894A patent/FR2674437B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-26 AT AT92400830T patent/ATE116547T1/de not_active IP Right Cessation
- 1992-03-26 EP EP92400830A patent/EP0506563B1/de not_active Expired - Lifetime
- 1992-03-26 ES ES92400830T patent/ES2067302T3/es not_active Expired - Lifetime
- 1992-03-26 DK DK92400830.3T patent/DK0506563T3/da active
- 1992-03-26 DE DE69201077T patent/DE69201077T2/de not_active Expired - Fee Related
-
1995
- 1995-03-13 GR GR950400536T patent/GR3015383T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0506563B1 (de) | 1995-01-04 |
| EP0506563A1 (de) | 1992-09-30 |
| FR2674437B1 (fr) | 1993-07-09 |
| FR2674437A1 (fr) | 1992-10-02 |
| DE69201077D1 (de) | 1995-02-16 |
| DK0506563T3 (da) | 1995-05-15 |
| GR3015383T3 (en) | 1995-06-30 |
| ES2067302T3 (es) | 1995-03-16 |
| DE69201077T2 (de) | 1995-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ294464A (en) | Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products | |
| IT1178235B (it) | Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione | |
| FI945081A0 (fi) | Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon | |
| FI935273A0 (fi) | En farmaceutisk komposition innnehaollande ett definierat lipidsystem | |
| NZ234143A (en) | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents | |
| ATE148630T1 (de) | Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen | |
| EP0136100A3 (en) | Sucralfate suspension for use in treating ulcers | |
| BR8905020A (pt) | Casca de psyllium e produtos contendo psyllium | |
| HUP9801414A2 (hu) | Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények | |
| GB2090529A (en) | Thrombosis-prophylactic and curing agent | |
| DE69201077D1 (de) | Alginsäure enthaltende Arzneisuspension. | |
| DK0764023T3 (da) | Forbindelser og præparater til administrering via oral inhalation eller insufflation | |
| ES2073512T3 (es) | Cristales de nitrofurantoina. | |
| SE8700157L (sv) | Sett att forhindra kvicksilverforgiftning orsakad av upplosning av kvicksilver ur amalgamplomber samt komposition herfor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |